Long noncoding RNA SNHG14 acts as an oncogene in prostate cancer via targeting miR-613

Eur Rev Med Pharmacol Sci. 2020 Nov;24(21):10919. doi: 10.26355/eurrev_202011_23556.

Abstract

Since this article has been suspected of research misconduct and the corresponding authors did not respond to our request to prove originality of data and figures, "Long noncoding RNA SNHG14 acts as an oncogene in prostate cancer via targeting miR-613, by B. Sun, K.-B. Ke, D.-F. Liu, Q. Wang, Y.-N. Li, J.-H. Chen, J.-H. Zhang, published in Eur Rev Med Pharmacol Sci 2020; 24 (2): 633-638-DOI: 10.26355/eurrev_202001_20039-PMID: 32016964" has been withdrawn. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/20039.

Publication types

  • Retraction of Publication